BioSpace News Archive

NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials

Genesys Spine is pleased to announce the launch of the first 3D Printed Non-Screw Based Cervical Stand-Alone Cage in the United States.

Hardwick, Massachusetts’ Eagle Hill School, a boarding and day school for grades 8-12, is the first school in the country to do a mass installation of Vystar Corporation’s RxAir 400® UV-C Light Air Purifier Systems throughout its campus, including classrooms, common areas and dormitories.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced today that clinical data from its NeuroStar Outcomes Registry, which suggests NeuroStar Advanced Therapy be evaluated as a first-line treatment for Major Depressive Disorder (MDD), will be published in the December 2020

The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). Date October 13, 2020 Time 11:30 AM (EDT) Location Sir John A Macdonald Building, Room 200 144 Wellington Street, Ottawa, Ontario The media availability will also be h

Disease education program aims to help patients, caregivers and families affected by Fabry disease to make informed healthcare decisions Program includes new resources for healthcare professionals to support strategies in diagnosis and disease management

Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst & Investor Meeting on Monday, October 26 th , 2020 in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. Presentations will begin at 1:00 pm ET ( 10:00 am PT ) and will conclude at 3:00 pm ET (12:0

Trait products largely relate to fungal-disease resistance and herbicide resistance in canola, further bolstering Cibus’ position as a leader in non-GMO input and agronomy traits SAN DIEGO--( BUSINESS WIRE )-- Cibus, a leader in input and agronomy trait products, announced today an additional 12 of its trait products have been designated as non-regulated by the United States Department of Agriculture’s Animal and Plant Health Inspection Service (USDA

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will host a Twist Biopharma Analyst & Investor Event on Friday, October 23, 2020. The event is scheduled to take place from 11:00 a.m. – 1:00 p.m. ET in a virtual format. The event will include an overview of Twist

Regulus Therapeutics Inc . (Nasdaq: RGLS) (the “Company” or “Regulus”), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced receipt of a total of $5 million in mi